United Therapeutics stalled in launching drug delivery system

Washington Business Journal

Dec 13, 2019

United Therapeutics Corp. (NASDAQ: UTHR) will look to launch its implantable pump for Remodulin, the company's flagship pulmonary arterial hypertension drug, later than planned. Th…